Corcept Therapeutics Inc. buy Canaccord Genuity Group Inc.
Start price
08.03.23
/
50%
€19.83
Target price
08.03.24
€30.31
Performance (%)
7.94%
End price
09.03.24
€21.40
Summary
This prediction ended on 09.03.24 with a price of €21.40. The BUY prediction by Canaccord_Genuity_Gr finished with a performance of 7.94%. Canaccord_Genuity_Gr has a follow-up prediction for Corcept Therapeutics Inc. where he still thinks Corcept Therapeutics Inc. is a Buy. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Corcept Therapeutics Inc. | 2.748% | 2.748% | -37.512% | 92.379% |
| iShares Core DAX® | 0,99 % | 8,31 % | 7,03 % | 49,79 % |
| iShares Nasdaq 100 | 2,07 % | 16,77 % | 35,95 % | 96,63 % |
| iShares Nikkei 225® | 2,27 % | 15,61 % | 46,57 % | 69,05 % |
| iShares S&P 500 | 1,04 % | 11,08 % | 26,46 % | 68,09 % |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Corcept Therapeutics Inc. diskutieren
Corcept Therapeutics Incorporated (NASDAQ: CORT) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $33.00 to $32.00. They now have a "buy" rating on the stock.
Ratings data for CORT provided by MarketBeat
In the thread Trading Corcept Therapeutics Inc.
Die von Canaccord_Genuity_Gr gewählte maximale Laufzeit wurde überschritten
Current prediction by Canaccord_Genuity_Gr for Corcept Therapeutics Inc.
Corcept Therapeutics Inc.
Start price
Target price
Perf. (%)
€33.55
26.03.26
26.03.26
€95.16
26.03.27
26.03.27
18.12%
30.04.26
30.04.26
